SCHEMBL984346

SCHEMBL984346

CCOc1cccc(C2OC=CO2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.49
CYP3A4 P08684 2/20 0.49
SMN1; SMN2 Q16637 3/20 0.41
BRD4 O60885 1/20 0.40
BRD2 P25440 1/20 0.40
CREBBP Q92793 1/20 0.40
ALDH1A1 P00352 4/20 0.40
MAPK1 P28482 2/20 0.40
TSHR P16473 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
HIF1A Q16665 1/20 0.40
LTA4H P09960 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
NQO1 P15559 1/20 0.39
KDM4E B2RXH2 3/20 0.39
RXRA P19793 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL984529 0.87 KMT2A (0.46) TP53CYP3A4SMN1; SMN2ALDH1A1TSHR
SCHEMBL984461 0.85 TSHR (0.46) SMN1; SMN2TSHRCYP1A2CYP2C19LTA4H
SCHEMBL767828 0.83 CYP3A4 (0.39) TP53CYP3A4SMN1; SMN2ALDH1A1TSHR
SCHEMBL981631 0.82 ALDH1A1 (0.40) TP53CYP3A4SMN1; SMN2BRD4ALDH1A1
SCHEMBL5346832 0.81 SMN1; SMN2 (0.39) TP53CYP3A4SMN1; SMN2ALDH1A1MAPK1
SCHEMBL746723 0.80 HTR2C (0.49) CYP3A4SMN1; SMN2ALDH1A1CYP2D6CYP2C19
SCHEMBL1276629 0.80 MAOB (0.46) TP53CYP3A4SMN1; SMN2ALDH1A1TSHR
SCHEMBL983385 0.80 TLR4 (0.45) TP53CYP3A4SMN1; SMN2ALDH1A1TSHR
SCHEMBL5725738 0.80 SMN1; SMN2 (0.38) TP53CYP3A4SMN1; SMN2ALDH1A1TSHR
SCHEMBL1276651 0.79 TSHR (0.41) CYP3A4SMN1; SMN2ALDH1A1MAPK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8445501-B2 Substituted 7-carboxamido-pyrrolo[3,2-d]pyrimidines TAKEDA GMBH (DE) 2013-05-21 US disclosed
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US disclosed
EP-2247594-A1 PYRROLOPYRIMIDINECARBOXAMIDES Nycomed GmbH (DE) 2010-11-10 EP disclosed
WO-2009106531-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2009-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE3A, PDE2A TP53 3683/4885CYP3A4 146/4885SMN1; SMN2 2319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.